Clinical Trials in Texas

Showing 12521-12540 of 12,973 trials

Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing®

NCT00475553

The purpose of this research study is to evaluate the best way to manage breakthrough spotting and bleeding during an extended use regimen of NuvaRing®. Ease of use and acceptability of a flexible regimen of NuvaRing® will also be evaluated. A comparison of cyclic mood symptoms, pelvic pain, and headaches will be made between a standard 21/7 regimen and an extended regimen.

Breakthrough BleedingBreakthrough Spotting

Scott and White Hospital & Clinic75 participantsStarted May 2006

Temple, Texas, United States

COMPLETEDPhase 255 miles

Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*

NCT00511368

The purpose of this study is to evaluate antiretroviral activity of up to five different oral doses administered for two weeks of bevirimat versus placebo in HIV treatment experienced patients, who have documented genotypic resistance to at least one major mutation from the IAS-USA list (2007)of resistance mutations for NRTIs, NNRTIs, or PIs. Patients will also be monitored for side effects, and the pharmacokinetics of bevirimat will be determined.

HIV Infections

Myrexis Inc.92 participantsStarted Apr 2006

Los Angeles, California, United States • San Francisco, California, United States • Denver, Colorado, United States +15 more locations

Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing®

Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*

Find Trials by Condition in Texas

A Phase III Trial For Patients With Metastatic Breast Cancer

Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)

Minimally Invasive Surgical Therapy for BPH

A Phase 1-2, XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast Cancer

Pegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9

Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity

Quality of Life in Pediatric Inflammatory Bowel Disease

Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome

Memory Impairment Study (Mild Cognitive Impairment Study)

Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age

Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML

Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis

A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation

North American Study for the Treatment of Refractory Ascites (NASTRA)

TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma

Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery

A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment